// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions?

Christopher Boulding - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

NIV retrieval service in a District General Hospital: an 18 month experience

Victoria Lewis - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reducing length of stay for patients with Motor Neurone Disease admitted to a Specialist Ventilation Unit

Emma Flowers - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Improving management of acute hypercapnic respiratory failure with Non-Invasive Ventilation

Ayantika Dhara - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Escalation decisions in ECOPD patients receiving acute NIV

Nicholas Lane - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Home non-invasive ventilation (NIV): what to do with telemonitored data?

Kinan El Husseini - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reducing COPD related readmission rates at Royal Stoke University Hospital (RSUH), UK: a Quality Improvement Project

Manoj Marathe - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The National Asthma and COPD Audit Programme in East Kent Hospitals University NHS Foundation Trust – The first year

Samantha Halliwell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

A new regional multidisciplinary clinic for children with difficult asthma

Lynsey Brown - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A home ventilation nursing and allied health professional network

Alison Armstrong - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COPD patients’ preferences for palliative conversations with clinicians

Nuno Tavares - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The effects of disease progression on work productivity: the Birmingham COPD Cohort

Kiran Rai - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Identification of late asthmatic reactions following specific inhalation challenge

Vicky Moore - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pesticide exposure and lung function: a systematic review and meta-analysis

Jate Ratanachina - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does the level of specific IgE to occupational allergens relate to the diagnosis of occupational asthma? A study in bakers and laboratory animal workers

Meinir Jones - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Mesothelioma mortality in Great Britain: how much longer will dockyards dominate?

Carl Reynolds - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Preconception air pollution exposure and early onset asthma and hay fever in the offspring

Ingrid Nordeide Kuiper - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Allergic rhinitis

N/A

Household Biomass Particulate Matter Increases Susceptibility to Streptococcus pneumoniae Infection

Lisa Miyashita - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Severe emphysema and not progressive fibrosis, as the long-term sequela of hypersensitivity pneumonitis caused by a contaminated humidifier

Gareth Walters - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Extrinsic allergic alveolitis

Prednisolone

Occupational asthma audit criteria - do they meet the needs of UK specialist clinicians?

Christopher Barber - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved